NEW YORK (Reuters Health) – Inhaled anticholinergics may increase the risk of community-acquired pneumonia in asthma patients, results of a Spanish case-control study suggest. The findings, published online…
NEW YORK (Reuters Health) – More than half of elderly patients who come out of the hospital after pneumonia either die within a year or get readmitted for…
NEW YORK (Reuters Health) – In patients with extensively drug-resistant tuberculosis (XDR TB), adding a later-generation fluoroquinolone to the treatment regimen may improve outcomes, even when drug-susceptibility testing…
NEW YORK (Reuters Health) – Across many subgroups of preterm infants, high-frequency oscillatory ventilation (HFOV) and conventional ventilation are just as likely to prevent bronchopulmonary dysplasia, and they…
NEW YORK (Reuters Health) – Starting antibiotics within the first two days of hospitalization for chronic obstructive pulmonary disease (COPD) significantly improved outcomes in a large cohort study…
NEW YORK (Reuters Health) – Beta-blockers can improve survival and reduce exacerbations of chronic obstructive pulmonary disease (COPD) – even in patients with cardiovascular disease, a new study…
NEW YORK (Reuters Health) – In preterm infants born at a gestational age of 32 weeks or younger, keeping oxygen saturation low in the first few weeks of…
NEW YORK (Reuters Health) – Giving a single antenatal course of intramuscular corticosteroids after 34 weeks of gestation significantly enhances fetal lung maturity in pregnancies with documented fetal…
NEW YORK (Reuters Health) – In mice, treating primary respiratory syncytial virus (RSV) with the cysteinyl leukotriene 1 receptor antagonist montelukast reduces airway hyperresponsiveness and inflammation after RSV…
NEW YORK (Reuters Health) – Adding inhaled treprostinil (Tyvaso) to oral bosentan for pulmonary arterial hypertension (PAH) improves exercise capacity and quality of life, according to a report…